• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

Month: April 2019

Editor's Choice

A Bright Outlook for Bacteriophage Applications

April 29, 2019 Jessica Sacher

Why Phages, and Why Now? Many modern diseases have been linked to alterations in the microbiome and changing it back could be the key to restoring health. Bacteriophages (phages) are viruses that kill bacteria with […]

Pharma & Human Health

DuPont to Provide Probiotics for International Pediatric Sepsis Research

April 26, 2019 Staff Editor

It is estimated that nearly 3 million newborns and 1.2 million children suffer from sepsis globally each year, with limited effective forms of prevention currently available. To help combat this, DuPont Nutrition & Biosciences (DuPont), […]

Editor's Choice

Interview with Nicola Segata, Winner of the Institut Mérieux – Pharmabiotics 2019 YIA Awards

April 17, 2019 Alessandra de Martino

This interview was originally published on the Biofortis Mérieux NutriSciences’ Blog. Pr Nicola Segata (Centre for Integrative Biology (CIBIO), University of Trento, Italy) received a €10,000 award from Institut Mérieux, on March 13th at Pharmabiotics 2019 to support his research […]

Pharma & Human Health

Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program

April 17, 2019 Staff Editor

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ:  EVGN) (TASE: EVGN), announced the initiation of pre-clinical studies for BMC-121 & BMC-127, two rationally-designed microbial consortia, in its therapeutic […]

Editor's Choice

Microbiome Profiling Techniques Reveal Effects of Iron Fortification on the Infant Gut Microbiome

April 16, 2019 Guus Kortman

Three studies published in the journal Gut over the past 5 years describe how the gut microbiome of African infants is affected not only by dietary iron but also by the combination of iron with antibiotics […]

Finance

Flagship Pioneering Unveils Kintai Therapeutics

April 16, 2019 Staff Editor

Kintai is pioneering precision therapeutics based on enteric signaling networks in the human body Flagship Pioneering, a unique life science innovation enterprise, today unveiled Kintai Therapeutics and named Paul-Peter Tak, M.D., Ph.D., as president, chief […]

Pharma & Human Health

MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD

April 11, 2019 Staff Editor

MaaT Pharma announced that the independent Data and Safety Monitoring Board (DSMB) recommended the continuation, without amendment, of the ongoing Phase II HERACLES study (NCT03359980). The HERACLES trial investigates the use of lead biotherapeutic MaaT013 […]

Pharma & Human Health

SkinBiotix® Shows Efficacy in First Human Study

April 8, 2019 Staff Editor

SkinBioTherapeutics plc (AIM: SBTX – “SkinBioTherapeutics” or the “Company”), a life science company focused on skin health, provides the results of its first human study. The study was primarily undertaken to show the effects of […]

Editor's Choice

Interview With Aoife Brennan, CEO, Synlogic Inc

April 7, 2019 Kristina Campbell

Kristina Campbell talks to Aoife Brennan to find out how Synlogic is pioneering the development of engineered probiotics to deliver specific functions in the human body to compliment for deficiencies brought about by disease.

Pharma & Human Health

C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage

April 3, 2019 Staff Editor

C3J Therapeutics, Inc. (C3J) a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials based on bacteriophage, announced that the United States Patent and Trademark Office (USPTO) has issued patent No. […]

Editor's Choice

The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms

April 3, 2019 Biofortis Mérieux NutriSciences and Cepton Strategies

Following Biofortis first paper The human microbiome: a global overview of clinical trials activity, this article compares the emergence of the human microbiome field with the rise of human genomics through a review on how […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

Market Reports
October 26, 2020
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new [...]

Editor’s Choice

  • Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
    January 20, 2021
  • Poor gut health connected to severe COVID-19, new review shows
    January 18, 2021
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Market Reports
  • Pharma & Human Health
  • Phytobiome & Environment
  • Premium Content
  • Reports
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter